The Journal of Minimally Invasive Gynecology
Volume 17, Issue 1 , Pages 66-69 , January 2010

Clinical and Sonographic Findings in Suspected Retained Trophoblast after Pregnancy Do Not Predict the Disorder

  • Ishai Levin, MD

      Affiliations

    • Department of Gynecology, Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
    • Corresponding Author InformationCorresponding author: Ishai Levin, MD, Department of Gynecology, Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel-Aviv, 69243, Israel.
    • These authors contributed equally to this work.
    • ,
  • Benny Almog, MD

      Affiliations

    • Sara Racine IVF Unit, Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
    • These authors contributed equally to this work.
    • ,
  • Baris Ata, MD

      Affiliations

    • McGill Reproductive Center, Royal Victoria Hospital, Montreal, Canada
    • ,
  • Gilad Ratan, MD

      Affiliations

    • Department of Gynecology, Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
    • ,
  • Ariel Many, MD

      Affiliations

    • Department of Gynecology, Lis Maternity Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

Received 30 August 2009 ,Accepted 4 November 2009.

References 

  1. Zalel Y, Cohen SB, Oren M, et al. Sonohysterography for the diagnosis of residual trophoblastic tissue. J Ultrasound Med. 2001;20:877–881
  2. McEwing RL, Anderson NG, Meates JB, Allen RB, Phillipson GT, Wells JE. Sonographic appearances of the endometrium after termination of pregnancy in asymptomatic versus symptomatic women. J Ultrasound Med. 2009;28:579–586
  3. van den Bosch T, Daemen A, Van Schoubroeck D, Pochet N, De Moor B, Timmerman D. Occurrence and outcome of residual trophoblastic tissue: a prospective study. J Ultrasound Med. 2008;27:357–361
  4. Tepper R, Beyth Y, Altaras MM, et al. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Gynecol Oncol. 1997;64:386–391
  5. Cohen SB, Kalter-Ferber A, Weisz BS, et al. Hysteroscopy may be the method of choice for management of residual trophoblastic tissue. J Am Assoc Gynecol Laparosc. 2001;8:199–202
  6. Goldenberg M, Schiff E, Achiron R, Lipitz S, Mashiach S. Managing residual trophoblastic tissue. Hysteroscopy for directing curettage. J Reprod Med. 1997;42:26–28
  7. Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome—one century later. Fertil Steril. 2008;89:759–779
  8. Schenker JG, Margalioth EJ. Intrauterine adhesions: an updated appraisal. Fertil Steril. 1982;37:593–610
  9. Schiff E, Ben-Baruch G, Moran O, et al. Prediction of residual trophoblastic tissue in first-trimester abortions and low levels of human chorionic gonadotropin beta-subunit. Am J Obstet Gynecol. 1990;162:797–801
  10. Ben-Ami I, Schneider D, Maymon R, Vaknin Z, Herman A, Halperin R. Sonographic versus clinical evaluation as predictors of residual trophoblastic tissue. Hum Reprod. 2005;20:1107–1111
  11. Achiron R, Goldenberg M, Lipitz S, Mashiach S. Transvaginal duplex Doppler ultrasonography in bleeding patients suspected of having residual trophoblastic tissue. Obstet Gynecol. 1993;81:507–511
  12. Alcazar JL. Transvaginal ultrasonography combined with color velocity imaging and pulsed Doppler to detect residual trophoblastic tissue. Ultrasound Obstet Gynecol. 1998;11:54–58

 The authors do not have any conflicts of interest or financial disclosures.

PII: S1553-4650(09)01243-6

doi: 10.1016/j.jmig.2009.11.002

The Journal of Minimally Invasive Gynecology
Volume 17, Issue 1 , Pages 66-69 , January 2010

Article Tools